These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

84 related items for PubMed ID: 5822248

  • 21. [Influencing of the coronary venous oxygen concentration in man using coronary-active drugs at various constant heart rates].
    Schwarzkopf HJ, Schaefer J, Schöttler M, Nordmann KJ.
    Verh Dtsch Ges Kreislaufforsch; 1972; 38():358-61. PubMed ID: 4663569
    [No Abstract] [Full Text] [Related]

  • 22. [Sympatholytic ("antisympathotonic") substances].
    Kruger K.
    Minerva Med; 1968 Dec 01; 59(96):5227-30. PubMed ID: 5710726
    [No Abstract] [Full Text] [Related]

  • 23. [On pharmacoogical effects on the nervous regulation of the coronary circulation].
    Kaverina NV.
    Vestn Akad Med Nauk SSSR; 1966 Dec 01; 21(4):9-15. PubMed ID: 6002421
    [No Abstract] [Full Text] [Related]

  • 24. [Effect of dalargin on the course of myocardial ischemia].
    Mikhaĭlova SD, Semushkina TM, Bebiakova NA.
    Kardiologiia; 1991 Jan 01; 31(1):13-5. PubMed ID: 2046237
    [Abstract] [Full Text] [Related]

  • 25. Effects of hexobendine on cardiac metabolism and blood supply.
    Raberger G, Kraupp O.
    Brux Med; 1970 Sep 01; 50(9):645-50. PubMed ID: 5510366
    [No Abstract] [Full Text] [Related]

  • 26. [Pharmacobiochemistry of the coronary agent N,N'-bis(3-(3',4',5'-trimethoxy-benzoyloxy)-propyl)-homopiperazine(dihydrochloride-monohydrate)].
    Schriewer H, Rauen HM.
    Arzneimittelforschung; 1972 Sep 01; 22(9):1455-9. PubMed ID: 4678606
    [No Abstract] [Full Text] [Related]

  • 27. [The influence of Hexobendin on the coronary arteriovenous O2 difference in humans].
    Hilger HH, Schaede A, Wagner J, Louven B, Wackerbauer J, Hellwig H.
    Z Kreislaufforsch; 1967 Feb 01; 56(2):164-79. PubMed ID: 5592238
    [No Abstract] [Full Text] [Related]

  • 28. ITF 296, a new endothelium-independent vasodilator: comparison with nitroglycerin and isosorbide dinitrate.
    Ghaleh B, Dubois-Randé JL, Hittinger L, Berdeaux A, Giudicelli JF.
    J Cardiovasc Pharmacol; 1995 Feb 01; 26 Suppl 4():S6-12. PubMed ID: 8839220
    [Abstract] [Full Text] [Related]

  • 29. Effect of magnesium asparaginate on the coronary circulation.
    Görög P, Ezer E, Szporny L.
    Arzneimittelforschung; 1966 Nov 01; 16(11):1488-90. PubMed ID: 6014963
    [No Abstract] [Full Text] [Related]

  • 30. [On pharmacological responses in cardiocirculatory insufficiency].
    Bretschneider HJ.
    Landarzt; 1965 Jul 20; 41(20):845-54. PubMed ID: 5840080
    [No Abstract] [Full Text] [Related]

  • 31. [Clinical aspects of persantin, segontin and trimanyl in the light of the results of experimental studies on the coronary circulation in dogs].
    Janicki K, Wcislo W.
    Pol Tyg Lek; 1967 May 22; 22(21):779-81. PubMed ID: 6040998
    [No Abstract] [Full Text] [Related]

  • 32. Verapamil: a selective antagonist of constrictor substances in dog coronary artery: implications for variant angina.
    Angus JA, Brazenor RM, Le Duc MA.
    Clin Exp Pharmacol Physiol Suppl; 1982 May 22; 6():15-28. PubMed ID: 6956474
    [Abstract] [Full Text] [Related]

  • 33. [Pharmacology of coronary circulation].
    Charlier R.
    Rev Med Liege; 1968 Apr 15; 23(8):232-46. PubMed ID: 5741676
    [No Abstract] [Full Text] [Related]

  • 34. Comparison of effects of nifedipine and nitroglycerin on large and small coronary arteries and cardiac function in conscious dogs.
    Hintze TH, Vatner SF.
    Circ Res; 1983 Feb 15; 52(2 Pt 2):I139-46. PubMed ID: 6403258
    [Abstract] [Full Text] [Related]

  • 35. [Continuous measurement of the coronary venous oxygen tension to test coronary active substances].
    Neuhaus KL, Gleichmann U, Kreuzer H.
    Naunyn Schmiedebergs Arch Exp Pathol Pharmakol; 1969 Feb 15; 263(1):185. PubMed ID: 5804229
    [No Abstract] [Full Text] [Related]

  • 36. [Application of a coronary vasodilator, Intensain in clinical anesthesia].
    Dan K.
    Masui; 1967 Jan 15; 16(1):61-5. PubMed ID: 6068641
    [No Abstract] [Full Text] [Related]

  • 37. [Hemodynamic and coronary effects of intravenous verapamil in coronary insufficiency].
    Zygelman M, Mérillon JP, Guiomard A, Eustigneff T, Zannier D, Gourgon R.
    Arch Mal Coeur Vaiss; 1981 Jun 15; 74(6):685-94. PubMed ID: 6794490
    [Abstract] [Full Text] [Related]

  • 38. Close relationship between the vasodilator response to acetylcholine in the brachial and coronary artery in suspected coronary artery disease.
    Takase B, Hamabe A, Satomura K, Akima T, Uehata A, Ohsuzu F, Ishihara M, Kurita A.
    Int J Cardiol; 2005 Oct 20; 105(1):58-66. PubMed ID: 16207546
    [Abstract] [Full Text] [Related]

  • 39. [Use of beta blockaders in arrhythmias and ischemic heart disease].
    Rosselot E.
    Rev Med Chil; 1982 Dec 20; 110(12):1224-32. PubMed ID: 6135249
    [No Abstract] [Full Text] [Related]

  • 40. [Beta receptor antagonists--pharmacologic characteristics and mechanism of action in cardiovascular diseases].
    Langnickel R, Bluth R.
    Z Arztl Fortbild (Jena); 1984 Dec 20; 78(7):255-61. PubMed ID: 6145258
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 5.